Solstein Capital’s Medtronic MDT Stock Holding History

Solstein Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29K	Hold	371	–	–	0.01%	265
2026 Q1	$32.1K	Hold	371	–	–	0.01%	258
2025 Q4	$35.6K	Hold	371	–	–	0.01%	239
2025 Q3	$35.3K	Sell	371 -355	-49%	-$32.6K	0.01%	228
2025 Q2	$63.3K	Buy	+726	New	+$61.6K	0.03%	179
2022 Q3	–	Sell	-280	Closed	-$25K	–	326
2022 Q2	$25K	Hold	280	–	–	0.02%	214
2022 Q1	$31K	Sell	280 -300	-52%	-$31.7K	0.02%	235
2021 Q4	$60K	Sell	580 -200	-26%	-$23.2K	0.04%	199
2021 Q3	$98K	Hold	780	–	–	0.06%	175
2021 Q2	$97K	Buy	780 +500	+179%	+$62.8K	0.12%	160
2021 Q1	$33K	Buy	+280	New	+$32.8K	0.04%	224
2020 Q2	–	Sell	-78	Closed	-$7K	–	277
2020 Q1	$7K	Sell	78 -351	-82%	-$37.3K	0.03%	206
2019 Q4	$49K	Buy	+429	New	+$47.1K	0.1%	113

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Solstein Capital's MDT Position: Q2 2026 in Review

Solstein Capital held its Medtronic (MDT) position steady in Q2 2026 at 371 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #265.

Solstein Capital first reported a position in MDT in Q4 2019 and has held it in 13 quarters since. The position peaked at $98K in Q3 2021. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Solstein Capital held 371 shares of Medtronic worth $29K as of Q2 2026.
Solstein Capital left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.01% of Solstein Capital's portfolio in Q2 2026, its #265 holding.
Solstein Capital first reported a position in Medtronic in Q4 2019 and has held it in 13 quarters since.
Solstein Capital's Medtronic position peaked at $98K in Q3 2021.
2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.